<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of risk factors for development of atherosclerosis and early cardiovascular disease in childhood
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of risk factors for development of atherosclerosis and early cardiovascular disease in childhood
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of risk factors for development of atherosclerosis and early cardiovascular disease in childhood
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jacob C Hartz, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sarah D de Ferranti, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David R Fulton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 18, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atherosclerotic vascular changes can begin in early childhood, setting the stage for atherosclerotic cardiovascular disease (ASCVD) events in adulthood. For most children, atherosclerotic vascular changes can be minimized or even prevented with adherence to a healthy lifestyle. However, in some children, the atherosclerotic process is accelerated because of the presence of identifiable risk factors  (
         <a class="graphic graphic_table graphicRef109927" href="/z/d/graphic/109927.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The evidence linking atherosclerotic changes in childhood to ASCVD later in life will be reviewed here. Related topics include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5753.html" rel="external">
          "Overview of the management of the child or adolescent at risk for atherosclerosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16972.html" rel="external">
          "Dyslipidemia in children and adolescents: Definition, screening, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/17048.html" rel="external">
          "Dyslipidemia in children and adolescents: Management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/121831.html" rel="external">
          "Familial hypercholesterolemia in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ATHEROSCLEROTIC CHANGES IN CHILDHOOD
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evidence for the development of atherosclerosis in childhood includes autopsy studies showing atherosclerotic changes in the young and noninvasive, indirect data in children and adolescents showing vascular changes that commonly precede adult ASCVD.
        </p>
        <p>
         In addition, these studies demonstrate an accelerated burden of vascular changes and premature atherosclerosis among children and adolescents with well-established ASCVD risk factors (eg, overweight/obesity, hypertension, dyslipidemia, and smoke exposure). These ASCVD risk factors often track into adulthood.
        </p>
        <p>
         These data, along with evidence from adult studies, are the basis for promoting healthy behaviors in childhood to prevent and reduce risk factors associated with premature atherosclerosis and, by extension, overt ASCVD. (See
         <a class="medical medical_review" href="/z/d/html/16975.html" rel="external">
          "Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5753.html" rel="external">
          "Overview of the management of the child or adolescent at risk for atherosclerosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31442039">
         <span class="h2">
          Direct evidence from autopsy studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Autopsy studies in children and young adults who have died of noncardiovascular causes demonstrate that atherosclerosis can begin in childhood. Findings in these studies included fatty streaks (accumulation of lipid-filled macrophages within the intima of the artery, which are early atherosclerotic changes) and fibrous plaques (a more advanced stage of atherosclerosis).
        </p>
        <p>
         Examples of these studies include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the Bogalusa Heart Study, autopsies performed in 204 young subjects (2 to 39 years of age, mean age 19.6 years) demonstrated fatty streaks in 50 percent of cases between 2 and 15 years of age and in 85 percent of older subjects between 21 and 39 years of age [
         <a href="#rid1">
          1
         </a>
         ]. The prevalence of raised fibrous plaques in the aorta and coronary arteries also increased with age from approximately 20 percent in subjects between 2 and 15 years of age to 70 percent in those between 26 and 39 years of age. The prevalence and the extent of atherosclerosis found in the aorta and coronary arteries were greater with increasing body mass index (BMI), blood pressure measurements, and levels of serum total cholesterol and low-density lipoprotein cholesterol (LDL-C). The degree of atherosclerotic changes increased with worsening severity and greater numbers of risk factors.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study examined the right coronary arteries and aortas in autopsies of 2876 individuals between 15 and 34 years of age [
         <a href="#rid2">
          2,3
         </a>
         ]. In subjects who were 15 to 19 years of age, raised fatty streaks were present in 10 percent of coronary arteries and 30 percent of aortas. The extent of fatty streaks increased with increasing age, elevated blood pressure, higher serum LDL-C, and lower serum high-density lipoprotein cholesterol. Female patients lagged by five years behind male patients in the progression of the extent of raised lesions in the right coronary arteries. In a subsequent report, individuals with early and more severe atherosclerotic changes were more likely to have had one or more ASCVD risk factor (including dyslipidemia, obesity, hyperglycemia, hypertension, or smoking) [
         <a href="#rid4">
          4
         </a>
         ]. The prevalence of risk factors among adolescents and young adults in the PDAY study mirror that of population-based data of general pediatric population [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent study examined autopsy reports of 3832 United States military service members who died in combat or due to unintentional injury between 2001 and 2011 [
         <a href="#rid6">
          6
         </a>
         ]. Mean age was 26 (range 18 to 59) years, and 98 percent were male. The presence of any coronary atherosclerosis was noted in 8.5 percent of deceased service members, with 2.3 percent having severe atherosclerosis (defined as ≥50 percent narrowing of one or more vessels). Those with any atherosclerosis had a higher prevalence of dyslipidemia, hypertension, and obesity. Interestingly, smoking did not appear to be a contributor in this study.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H235229608">
         <span class="h2">
          Evidence of subclinical atherosclerosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies using noninvasive imagining to evaluate vascular changes in children and adolescents provide indirect evidence for early development of atherosclerosis, which is associated with ASCVD in adulthood [
         <a href="#rid7">
          7,8
         </a>
         ]. These indirect measures include changes in vessel anatomy (ie, increased intima-media thickness [IMT] and coronary calcification), mechanical changes (ie, decreased arterial distensibility or increased stiffness), and physiologic changes (ie, decreased flow mediated vasodilatation) [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Carotid IMT (CIMT)
         </strong>
         – Adults with increased CIMT detected by ultrasonography have a higher likelihood of experiencing an ASCVD event. Among children and adolescents, increased CIMT may be seen in patients with certain high-risk conditions (eg, familial hypercholesterolemia [FH]) and in children with ASCVD risk factors (ie, family history of premature ASCVD, overweight, dyslipidemia, hypertension, diabetes mellitus [DM]) [
         <a href="#rid9">
          9-19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16307.html" rel="external">
          "Overview of possible risk factors for cardiovascular disease", section on 'Arterial intima-media thickness'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arterial stiffness
         </strong>
         – Arterial stiffness can be measured with the pulse wave velocity (PWV), which is the speed at which an aortic pulse travels between arteries in the upper body to the lower body (typically measured as the brachial-ankle PWV). In adults, increased arterial stiffness is associated with a higher likelihood of ASCVD. PWV measurements vary among adolescents and young adults based upon sex, age, and ethnicity [
         <a href="#rid20">
          20
         </a>
         ]. A high burden of ASCVD risk factors (ie, high BMI, hypertension, hypertriglyceridemia, glucose intolerance) is associated with higher PWV in adolescents and young adults, even after adjusting for age and sex [
         <a href="#rid20">
          20-22
         </a>
         ]. Increased arterial stiffness can lead to cardiac remodeling and is associated with higher left ventricular mass in adolescents and young adults [
         <a href="#rid23">
          23
         </a>
         ]. In one study of 670 adolescents and young adults (age range 10 to 24 years) stratified into three groups based upon BMI (lean [BMI &lt;85
         <sup>
          th
         </sup>
         percentile], overweight and obese [BMI ≥85
         <sup>
          th
         </sup>
         percentile], and overweight/obese with type 2 DM), there was a progressive increase in PWV from the lean group to the obese and obese/type 2 DM groups [
         <a href="#rid24">
          24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16307.html" rel="external">
          "Overview of possible risk factors for cardiovascular disease", section on 'Arterial stiffness'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Flow-mediated dilation
         </strong>
         – Flow-mediated dilation (FMD) measures the endothelial response to an adverse stimulus (eg, ischemia induced by an inflated blood pressure cuff) by brachial artery ultrasonography (also referred to as brachial artery reactivity). Lower brachial artery reactivity has been identified in children with obesity [
         <a href="#rid14">
          14
         </a>
         ], a family history of premature coronary disease [
         <a href="#rid15">
          15
         </a>
         ], type 1 DM, and Kawasaki disease with aneurysms. (See
         <a class="medical medical_review" href="/z/d/html/1532.html" rel="external">
          "Coronary endothelial dysfunction: Clinical aspects", section on 'Noninvasive testing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Numerous longitudinal studies have demonstrated an association between the traditional ASCVD risk factors (ie, dyslipidemia, obesity, hypertension, smoke exposure, and DM) during childhood and evidence of early atherosclerotic changes in adulthood based upon one or more of the above measures (CIMT, PWV, and/or FMD).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bogalusa study – In a cohort of 486 adults (age range 25 to 37 years), childhood measurements of LDL-C levels and BMI positively predicted CIMT [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Muscatine study – In a cohort of 725 adults (age range 33 to 42 years), childhood total cholesterol levels and BMI were predictors of CIMT in adulthood [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiovascular Risk in Young Finns study – In a cohort of Finnish patients followed for &gt;25 years, CIMT increased as the number of ASCVD risk factors increased [
         <a href="#rid25">
          25
         </a>
         ]. In particular, elevated childhood levels of LDL-C and insulin, as well as obesity, were predictive of increased CIMT [
         <a href="#rid26">
          26
         </a>
         ]. In subsequent studies, carotid artery elasticity decreased as the number of childhood ASCVD risk factors increased and FMD was lower in male patients who had hypertension during adolescence [
         <a href="#rid27">
          27,28
         </a>
         ]. In this cohort, exposure to ASCVD risk factors over time correlated with the extent of coronary artery calcification by computed tomography [
         <a href="#rid29">
          29,30
         </a>
         ]. In follow-up studies of this cohort at age 34 to 49 years, the number of early life ASCVD risk factors correlated with worse midlife cognitive function [
         <a href="#rid31">
          31,32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coronary Artery Risk Development in Young Adults (CARDIA) study – In a cohort of patients initially recruited at 18 to 30 years of age and followed for 15 years, baseline ASCVD risk factors (smoking, dyslipidemia, glucose intolerance, hypertension) were associated with increased risk of coronary artery calcification later in life [
         <a href="#rid33">
          33,34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         i3C studies (international Childhood Cardiovascular Cohort Consortium) – In an analysis of combined data from the above four prospective studies, the number of childhood ASCVD risk factors (eg, dyslipidemia, hypertension, high BMI) was associated with elevated adult CIMT, even in children as young as nine years of age [
         <a href="#rid13">
          13
         </a>
         ]. A childhood ASCVD risk score that included five variables (BMI, systolic blood pressure, total cholesterol, triglyceride level, and youth smoking) correlated with risk of ASCVD events in midlife [
         <a href="#rid35">
          35
         </a>
         ]. Further studies have shown that dyslipidemia in adolescence was also predictive of increased adult CIMT, even after accounting for sex, obesity, and hypertension [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3139061685">
         <span class="h1">
          RISK STRATIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         As discussed in the previous section, traditional risk factors for atherosclerotic cardiovascular disease (ASCVD) and other specific conditions in children and adolescents are associated with accelerated atherosclerosis and early ASCVD. We agree with the risk stratification schema established by the American Heart Association, which is similar to but slightly modifies the previous schema proposed by an expert panel convened by the National Heart, Lung, and Blood Institute  (
         <a class="graphic graphic_algorithm graphicRef54963" href="/z/d/graphic/54963.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p>
         ASCVD risk conditions are categorized as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          High-risk conditions
         </strong>
         include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Homozygous familial hypercholesterolemia (FH) (see
         <a class="local">
          'Dyslipidemia'
         </a>
         below and
         <a class="local">
          'Familial hypercholesterolemia'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diabetes mellitus (DM; type 1 or type 2) (see
         <a class="local">
          'Diabetes mellitus'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         End-stage kidney disease (see
         <a class="local">
          'Chronic kidney disease'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Kawasaki disease with persistent coronary aneurysms (see
         <a class="local">
          'Kawasaki disease'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Solid-organ transplant vasculopathy (see
         <a class="local">
          'Transplant vasculopathy'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Childhood cancer survivor following stem cell transplantation (see
         <a class="local">
          'Childhood cancer'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Moderate-risk conditions
         </strong>
         include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe obesity (body mass index [BMI] ≥99
         <sup>
          th
         </sup>
         percentile or a BMI ≥35 kg/m
         <sup>
          2
         </sup>
         ) (see
         <a class="local">
          'Obesity'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Confirmed hypertension (blood pressure &gt;95
         <sup>
          th
         </sup>
         percentile or ≥130/80 mmHg on three separate occasions) (see
         <a class="local">
          'Hypertension'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Heterozygous FH (see
         <a class="local">
          'Dyslipidemia'
         </a>
         below and
         <a class="local">
          'Familial hypercholesterolemia'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Predialysis chronic kidney disease (CKD) (see
         <a class="local">
          'Chronic kidney disease'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Aortic stenosis or coarctation (see
         <a class="local">
          'Congenital heart disease'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Childhood cancer survivor with exposure to chest irradiation (see
         <a class="local">
          'Childhood cancer'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          At-risk conditions
         </strong>
         include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Obesity that is not severe (BMI ≥95
         <sup>
          th
         </sup>
         to &lt;99
         <sup>
          th
         </sup>
         percentile) (see
         <a class="local">
          'Obesity'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Insulin resistance with comorbidities (eg, nonalcoholic fatty liver disease, polycystic ovary syndrome) (see
         <a class="local">
          'Diabetes mellitus'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         White-coat hypertension (elevated blood pressure measurements in the office with normal values outside of the office setting) (see
         <a class="local">
          'Hypertension'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic inflammatory disease (eg, systemic lupus erythematosus [SLE], juvenile idiopathic arthritis) (see
         <a class="local">
          'Chronic inflammatory diseases'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HIV infection (see
         <a class="local">
          'HIV infection'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Kawasaki disease with regressed coronary aneurysms (see
         <a class="local">
          'Kawasaki disease'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiomyopathy (eg, hypertrophic cardiomyopathy) (see
         <a class="medical medical_review" href="/z/d/html/4951.html" rel="external">
          "Hypertrophic cardiomyopathy in children: Clinical manifestations and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Surgically repaired congenital heart disease (CHD) involving coronary artery translocation (eg, transposition of the great arteries repair) (see
         <a class="local">
          'Congenital heart disease'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Childhood cancer survivor with cardiotoxic chemotherapy only (see
         <a class="local">
          'Childhood cancer'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adolescent depressive and bipolar disorders (see
         <a class="local">
          'Depressive and bipolar disorders'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         Children initially placed in the moderate-risk or at-risk tier based on their primary diagnosis should be moved to a higher tier if they have additional risk factors  (
         <a class="graphic graphic_algorithm graphicRef54963" href="/z/d/graphic/54963.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Traditional ASCVD risk factors'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          TRADITIONAL ASCVD RISK FACTORS
         </span>
        </p>
        <p class="headingAnchor" id="H169814611">
         <span class="h2">
          Background
         </span>
         <span class="headingEndMark">
          —
         </span>
         In adults, several large prospective population-based studies have shown that multiple risk factors (eg, increased body mass index [BMI], hypertension, dyslipidemia, diabetes mellitus [DM], and family history of ASCVD) are associated with higher risk of ASCVD. (See
         <a class="medical medical_review" href="/z/d/html/1506.html" rel="external">
          "Overview of established risk factors for cardiovascular disease"
         </a>
         .)
        </p>
        <p>
         These ASCVD risk factors are common in the pediatric population. In studies using data from the United States National Health and Nutrition Examination Survey (NHANES), the reported prevalence of ASCVD risk factors in children and adolescents age 8 to 19 years were [
         <a href="#rid40">
          40-43
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dyslipidemia – 20 to 30 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prediabetes/DM – 15 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood pressure (BP) in the hypertensive range – 8 to 14 percent
        </p>
        <p>
        </p>
        <p>
         While data linking these risk factors in childhood to cardiovascular events are limited, these risk factors are associated with acceleration of atherosclerosis in children based on autopsy data and measures of subclinical atherosclerosis based on noninvasive imaging (see
         <a class="local">
          'Atherosclerotic changes in childhood'
         </a>
         above). In addition, longitudinal studies demonstrate a reasonably strong correlation between childhood blood pressure, serum lipid levels, and BMI with analogous values measured in middle age [
         <a href="#rid44">
          44
         </a>
         ]. Thus, children with ASCVD risk factors are more likely to be at-risk adults.
        </p>
        <p>
         Children with specific disease states (eg, familial hypercholesterolemia [FH], DM, and chronic kidney disease) also are more likely to develop atherosclerosis and ASCVD at an earlier age. In extreme cases, patients may experience cardiovascular events during childhood or adolescence. (See
         <a class="local">
          'Other conditions'
         </a>
         below.)
        </p>
        <p>
         A study using NHANES data of adolescents and young adults (12 to 39 years of age) enrolled from 1988 to 1994 demonstrated that DM (eg, high hemoglobin A1c levels), central obesity (weight-to-height ratio ≥0.65), and smoking were associated with an increased risk for death before 55 years of age after accounting for age, sex, and race/ethnicity [
         <a href="#rid45">
          45
         </a>
         ]. Because there were relatively few deaths, it was not possible to determine whether these factors were associated with specific causes of death (eg, cardiovascular deaths).
        </p>
        <p>
         Risk factors and diseases associated with premature atherosclerosis generally do not occur in isolation but often cluster and the risk of premature ASCVD rises as the number of risk factors increases [
         <a href="#rid1">
          1,13,25,42
         </a>
         ]. As an example, in one of the above NHANES studies, the risk of one or more additional ASCVD risk factors rose with increasing BMI as follows (37 percent for adolescents with normal BMI, 49 percent for those with overweight BMI, and 61 percent for those with obesity) [
         <a href="#rid42">
          42
         </a>
         ]. Among adolescents with obesity, 8 percent had ≥3 additional ASCVD risk factors. These data highlight the high prevalence of ASCVD risk factors in adolescents in the United States, especially among individuals with obesity.
        </p>
        <p>
         The association between elevated BMI on other ASCVD risk factors was described in a meta-analysis of 63 observational studies, including &gt;49,000 children [
         <a href="#rid46">
          46
         </a>
         ]. Compared with children with healthy weight, those with obesity had higher systolic BP (mean difference 7.5 mmHg), higher total cholesterol (mean difference 6 mg/dL [0.15 mmol/L]), higher triglyceride levels (mean difference 23 mg/dL [0.26 mmol/L]), and increased left ventricular size.
        </p>
        <p class="headingAnchor" id="H352469615">
         <span class="h2">
          Dyslipidemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dyslipidemias are disorders of lipoprotein metabolism that result in at least one of the following abnormalities  (
         <a class="graphic graphic_table graphicRef68183" href="/z/d/graphic/68183.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid38">
          38
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         High total cholesterol
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         High low-density lipoprotein cholesterol (LDL-C)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low high-density lipoprotein cholesterol
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         High triglycerides
        </p>
        <p>
        </p>
        <p>
         Dyslipidemia is a well-established risk factor for ASCVD in adults. (See
         <a class="medical medical_review" href="/z/d/html/4565.html" rel="external">
          "Lipoprotein classification, metabolism, and role in atherosclerosis"
         </a>
         .)
        </p>
        <p>
         Evidence linking pediatric dyslipidemia with risk of premature ASCVD includes the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Studies involving children with monogenic causes of dyslipidemia such as familial hypercholesterolemia (FH), which are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/121831.html" rel="external">
          "Familial hypercholesterolemia in children", section on 'Benefits of statin therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An analysis of data from i3C (international Childhood Cardiovascular Cohort) consortium showed the risk of cardiovascular events increased 1.3 fold for each unit increase in childhood cholesterol levels [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Studies demonstrating associations between pediatric dyslipidemia and preclinical atherosclerosis (eg, carotid intima-media thickness [CIMT]) in adulthood or atherosclerotic lesions on autopsy. These studies are discussed above. (See
         <a class="local">
          'Atherosclerotic changes in childhood'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         The evaluation and management of children with abnormal lipid profiles are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16972.html" rel="external">
          "Dyslipidemia in children and adolescents: Definition, screening, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/17048.html" rel="external">
          "Dyslipidemia in children and adolescents: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the previously discussed autopsy studies, BMI was positively correlated with more extensive atherosclerotic changes in the aorta and coronary arteries during childhood. (See
         <a class="local">
          'Direct evidence from autopsy studies'
         </a>
         above.)
        </p>
        <p>
         There is also evidence demonstrating that higher BMI during childhood is associated with increased risk of ASCVD in adulthood. This was illustrated by a large prospective cohort study of 276,835 Danish children who were born from 1930 to 1976 for whom childhood BMI measurements were available from mandatory school examinations [
         <a href="#rid47">
          47
         </a>
         ]. Ischemic coronary events (eg, angina pectoris, acute myocardial infarction, other ischemic heart disease) were determined for each subject through a national registry that was established in 1968. There was a positive linear association between increasing BMI at every age from 7 to 13 years and the number of events in adulthood, with stronger associations in males as compared with females. The effect of excess weight on the risk of an event rose with increasing age. Relatively small increases in weight in childhood were associated with increased ASCVD risk in adulthood.
        </p>
        <p>
         Other studies have shown that children or adolescents who are overweight (defined as BMI ≥85
         <sup>
          th
         </sup>
         percentile) or obese (defined as BMI percentile &gt;95
         <sup>
          th
         </sup>
         percentile), compared with normal-weight children, are more likely to be hypertensive, have dyslipidemia, develop insulin resistance and type 2 DM, and develop ASCVD as they age [
         <a href="#rid48">
          48,49
         </a>
         ]. The cardiovascular comorbidities and complications of obesity in childhood are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5869.html" rel="external">
          "Overview of the health consequences of obesity in children and adolescents", section on 'Cardiovascular'
         </a>
         .)
        </p>
        <p>
         As mentioned previously, studies that have assessed indirect measures of atherosclerosis (eg, CIMT, flow-mediated dilation) have found evidence of subclinical atherosclerosis among overweight and obese youth [
         <a href="#rid14">
          14,18,24
         </a>
         ]. Overweight children are also more likely to be inactive, have obstructive sleep apnea, and have increased left ventricular mass, all of which are associated with ASCVD in adults. (See
         <a class="medical medical_review" href="/z/d/html/5874.html" rel="external">
          "Definition, epidemiology, and etiology of obesity in children and adolescents", section on 'Persistence into adulthood'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5370.html" rel="external">
          "Overweight and obesity in adults: Health consequences"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3049166410">
         <span class="h2">
          Diabetes mellitus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Insulin resistance, hyperinsulinemia, and elevated blood glucose are associated with ASCVD. In addition, children with DM compared with those without DM are at increased risk for other ASCVD risk factors, such as hypertension and dyslipidemia. (See
         <a class="medical medical_review" href="/z/d/html/1542.html" rel="external">
          "Prevalence of and risk factors for coronary heart disease in patients with diabetes mellitus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1506.html" rel="external">
          "Overview of established risk factors for cardiovascular disease", section on 'Diabetes mellitus'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type 1 DM
         </strong>
         – In adolescents with type 1 DM, accelerated atherosclerotic changes have been described at autopsy and in studies demonstrating preclinical markers of atherosclerosis (eg, increased CIMT), abnormal arterial stiffness, and impaired endothelial function [
         <a href="#rid50">
          50
         </a>
         ]. There have also been reports of myocardial infarctions in young adults with type 1 DM.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type 2 DM
         </strong>
         – In adolescents with type 2 DM, cardiovascular abnormalities, such as increased left ventricular wall thickness and increased arterial stiffness, have been reported. Children with type 2 DM often have comorbid obesity and are at increased risk of developing metabolic syndrome (also referred to as syndrome X or insulin resistance syndrome), a condition of multiple ASCVD risk factors (ie, dyslipidemia, hypertension, type 2 DM, and obesity). (See
         <a class="local">
          'Metabolic syndrome'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/1784.html" rel="external">
          "Metabolic syndrome (insulin resistance syndrome or syndrome X)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The management of types 1 and 2 DM, including screening and prevention of ASCVD, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5818.html" rel="external">
          "Complications and screening in children and adolescents with type 1 diabetes mellitus", section on 'Cardiovascular disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5826.html" rel="external">
          "Chronic complications and screening in children and adolescents with type 2 diabetes mellitus", section on 'Other microvascular complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Metabolic syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The constellation of ASCVD risk factors that includes type 2 DM, abdominal obesity, hyperglycemia, dyslipidemia, and hypertension is referred to as metabolic syndrome. In adults, metabolic syndrome is associated with an increased risk of ASCVD and all-cause mortality.
        </p>
        <p>
         In a report using data from the National Heart, Lung, and Blood Institute Lipid Research Clinics Princeton Prevalence Study and the Princeton Follow-up Study, children between the ages of 6 to 19 years who were identified as meeting criteria for metabolic syndrome had a &gt;10-fold higher risk of ASCVD at 25-year follow-up compared with the general school-age population (odds ratio 14.6, 95% CI 4.8-45.3) [
         <a href="#rid51">
          51
         </a>
         ]. They also were more likely to have metabolic syndrome in adulthood (odds ratio 6.2, 95% CI 2.8-13.8).
        </p>
        <p>
         The concept of metabolic syndrome in childhood is primarily used in research; it is not used in routine clinical care, because the relationship between childhood metabolic syndrome and ASCVD events is not well characterized and there is no consensus on the pediatric definition [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1784.html" rel="external">
          "Metabolic syndrome (insulin resistance syndrome or syndrome X)", section on 'Children and adolescents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Hypertension
         </span>
         <span class="headingEndMark">
          —
         </span>
         In adults, hypertension is a well-established risk factor for ASCVD. (See
         <a class="medical medical_review" href="/z/d/html/3850.html" rel="external">
          "Cardiovascular risks of hypertension"
         </a>
         .)
        </p>
        <p>
         In children, data directly linking hypertension with ASCVD are lacking. However, hypertension is associated with preclinical evidence of accelerated atherosclerosis (ie, increased CIMT and arterial stiffness). (See
         <a class="local">
          'Atherosclerotic changes in childhood'
         </a>
         above.)
        </p>
        <p>
         In addition, patients with elevated blood pressure in childhood are more likely to have hypertension in adulthood.
        </p>
        <p>
         The evaluation and treatment of hypertension in children and adolescents are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6087.html" rel="external">
          "Definition and diagnosis of hypertension in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6131.html" rel="external">
          "Nonemergent treatment of hypertension in children and adolescents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Family history
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals with first-degree relatives (parent or sibling) who have experienced premature ASCVD are at increased risk of ASCVD. Premature ASCVD in this context is generally defined as myocardial infarction, treated angina, interventions for coronary artery disease, sudden cardiac death, or ischemic stroke before age 55 (males) or 65 (females). (See
         <a class="medical medical_review" href="/z/d/html/1506.html" rel="external">
          "Overview of established risk factors for cardiovascular disease", section on 'Family history'
         </a>
         .)
        </p>
        <p>
         In children, subclinical vascular abnormalities can be seen among offspring of individuals with premature ASCVD. Evidence of accelerated atherosclerosis (eg, lower brachial arterial reactivity and greater CIMT) is more commonly detected in adolescent offspring of individuals with premature myocardial infarction compared with controls without a family history of premature ASCVD [
         <a href="#rid15">
          15
         </a>
         ]. However, the sensitivity of a positive family history for detection of ASCVD or dyslipidemia appears to be relatively low. Several studies have shown that a positive family history fails to detect 30 to 60 percent of children with dyslipidemia [
         <a href="#rid53">
          53
         </a>
         ] and that the risk of dyslipidemia may be independent of a family history of ASCVD [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16972.html" rel="external">
          "Dyslipidemia in children and adolescents: Definition, screening, and diagnosis", section on 'Rationale for lipid screening'
         </a>
         .)
        </p>
        <p>
         Nevertheless, individuals with a family history positive for early ASCVD disease have twice the risk of ASCVD as those without, even after adjusting for conventional risk factors [
         <a href="#rid55">
          55
         </a>
         ]. The impact of a positive family history upon ASCVD is more fully discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1506.html" rel="external">
          "Overview of established risk factors for cardiovascular disease", section on 'Family history'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/50.html" rel="external">
          "Coronary artery disease and myocardial infarction in young people", section on 'Family history'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Nicotine exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoke exposure, including secondhand cigarette smoke, increases the risk of ASCVD [
         <a href="#rid56">
          56
         </a>
         ]. Because of its addictive nature, pediatric tobacco use increases the risk of persistent adult smoking. The risk of CVD due to smoke exposure is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1504.html" rel="external">
          "Cardiovascular risk of smoking and benefits of smoking cessation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6375.html" rel="external">
          "Secondhand smoke exposure: Effects in children", section on 'Atherogenesis'
         </a>
         .)
        </p>
        <p>
         There is also evidence that the use of electronic nicotine delivery systems also may increase the risk of hypertension and ASCVD [
         <a href="#rid57">
          57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/98400.html" rel="external">
          "Vaping and e-cigarettes", section on 'Adverse health effects'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2233188970">
         <span class="h1">
          MODIFIABLE HEALTH BEHAVIORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following health behaviors, while not considered independent risk factors for ASCVD per se, are nevertheless important aspects of promoting a heart-healthy lifestyle. These behaviors often contribute to some of the risk factors discussed above (eg, obesity, type 2 diabetes, dyslipidemia, hypertension). (See
         <a class="medical medical_review" href="/z/d/html/16975.html" rel="external">
          "Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3599421078">
         <span class="h2">
          Diet
         </span>
         <span class="headingEndMark">
          —
         </span>
         For all children, health care providers should promoting a heart-healthy diet that is rich in vegetables, fruits, and whole grains; low in saturated fat; and devoid of trans fats  (
         <a class="graphic graphic_table graphicRef79084" href="/z/d/graphic/79084.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/2866.html" rel="external">
          "Dietary recommendations for toddlers and preschool and school-age children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20824989">
         <span class="h2">
          Physical activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evidence from both adult and pediatric studies demonstrates that daily vigorous activity and reduction in sedentary behavior improves cardiovascular health and decreases the risk of ASCVD in adulthood. The American Academy of Pediatrics and the National Heart, Lung, and Blood Institute expert panels recommend age-based daily activity for all children as summarized in the table  (
         <a class="graphic graphic_table graphicRef75748" href="/z/d/graphic/75748.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16975.html" rel="external">
          "Pediatric prevention of adult cardiovascular disease: Promoting a healthy lifestyle and identifying at-risk children", section on 'Physical activity'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1510.html" rel="external">
          "Exercise and fitness in the prevention of atherosclerotic cardiovascular disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3746971856">
         <span class="h2">
          Sleep habits
         </span>
         <span class="headingEndMark">
          —
         </span>
         In adults, abnormal sleep duration (both too little and too much) and sleep disordered breathing (eg, obstructive sleep apnea) have been linked to increased risk of ASCVD. These associations are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7715.html" rel="external">
          "Insufficient sleep: Definition, epidemiology, and adverse outcomes", section on 'Cardiovascular morbidity'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7705.html" rel="external">
          "Obstructive sleep apnea and cardiovascular disease in adults"
         </a>
         .)
        </p>
        <p>
         There are fewer data establishing a link between sleep problems in childhood and risk of premature ASCVD. Nevertheless, establishing healthy sleep habits  (
         <a class="graphic graphic_table graphicRef52760 graphicRef120097" href="/z/d/graphic/52760.html" rel="external">
          table 5A-B
         </a>
         ), including appropriate duration of sleep  (
         <a class="graphic graphic_figure graphicRef106597" href="/z/d/graphic/106597.html" rel="external">
          figure 1
         </a>
         ), is generally considered part of a heart-healthy lifestyle. (See
         <a class="medical medical_review" href="/z/d/html/6357.html" rel="external">
          "Assessment of sleep disorders in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          OTHER CONDITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to the risk factors listed above, other conditions that are associated with accelerated atherosclerosis and premature ASCVD include the following  (
         <a class="graphic graphic_algorithm graphicRef54963" href="/z/d/graphic/54963.html" rel="external">
          algorithm 1
         </a>
         and
         <a class="graphic graphic_table graphicRef109927" href="/z/d/graphic/109927.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid38">
          38,39,58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H479818557">
         <span class="h2">
          Familial hypercholesterolemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Familial hypercholesterolemia (FH) is an autosomal codominant genetic disease. The clinical syndrome (phenotype) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) level from birth, xanthomata in untreated adults and patients with homozygous FH, and a propensity to early-onset ASCVD. FH is inherited with a gene-dosing effect, in which homozygotes are more adversely affected than heterozygotes  (
         <a class="graphic graphic_figure graphicRef105115" href="/z/d/graphic/105115.html" rel="external">
          figure 2
         </a>
         ). Heterozygous FH is fairly common (estimated to occur in approximately 1 in 200 to 300 individuals), whereas homozygous FH is a rare disorder.
        </p>
        <p>
         The diagnosis and treatment of FH are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/121831.html" rel="external">
          "Familial hypercholesterolemia in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/121831.html" rel="external">
          "Familial hypercholesterolemia in children", section on 'Management'
         </a>
         .)
        </p>
        <p>
         Children with other monogenetic defects or with a high abundance of polygenic contributions can have a phenotype similar to FH. (See
         <a class="medical medical_review" href="/z/d/html/4567.html" rel="external">
          "Inherited disorders of LDL-cholesterol metabolism other than familial hypercholesterolemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3181068732">
         <span class="h2">
          Chronic kidney disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with chronic kidney disease (CKD) are at increased risk for developing ASCVD. Accelerated atherosclerosis has been demonstrated in iliac artery samples at the time of renal transplantation and at autopsy [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p>
         Children with CKD often have additional ASCVD risk factors, including hypertension and dyslipidemia. Studies have demonstrated evidence of preclinical atherosclerosis (eg, coronary artery calcification, abnormal flow-mediated dilation [FMD], increased carotid intima-medial thickness [CIMT], increased aortic stiffness) and left ventricular hypertrophy in pediatric patients with CKD [
         <a href="#rid60">
          60-65
         </a>
         ]. These abnormalities seem to be, in part, related to the degree of uremia. In addition, some medications used to prevent renal transplant rejection are associated with ASCVD risk factors (eg,
         <a class="drug drug_pediatric" data-topicid="13193" href="/z/d/drug information/13193.html" rel="external">
          cyclosporine
         </a>
         is associated with hypertension; rapamycin is associated with dyslipidemia; corticosteroids are associated with hypertriglyceridemia, hypertension, and diabetes mellitus [DM]). (See
         <a class="medical medical_review" href="/z/d/html/128353.html" rel="external">
          "Chronic kidney disease in children: Complications", section on 'Risk for cardiovascular disease'
         </a>
         .)
        </p>
        <p>
         Individuals with childhood-onset nephrotic syndrome are at increased risk for early atherosclerosis in part due to hyperlipidemia, which is a characteristic feature of nephrotic syndrome. Other factors that may play a role include chronic inflammation, hypercoagulability, and the effects of corticosteroid therapy. Studies have demonstrated evidence of preclinical atherosclerosis (increased CIMT, abnormal FMD]) in patients with childhood-onset nephrotic syndrome [
         <a href="#rid66">
          66-68
         </a>
         ]. Complications of pediatric nephrotic syndrome and clinical implications of lipid abnormalities in nephrotic syndrome are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6102.html" rel="external">
          "Complications of nephrotic syndrome in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3114.html" rel="external">
          "Lipid abnormalities in nephrotic syndrome", section on 'Clinical implications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H924005801">
         <span class="h2">
          Kawasaki disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Kawasaki disease (also called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood and is associated with the development of coronary artery aneurysms, which can lead to myocardial ischemia or infarction  (
         <a class="graphic graphic_movie graphicRef65317" href="/z/d/graphic/65317.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef53864" href="/z/d/graphic/53864.html" rel="external">
          movie 2
         </a>
         ). In developed countries, Kawasaki disease has surpassed rheumatic fever as the leading cause of acquired cardiovascular disease in childhood.
        </p>
        <p>
         The risk of ASCVD in patients with a history of Kawasaki disease depends upon initial aneurysm size, occurrence of coronary thrombosis, and degree and nature of remodeling of the arterial wall over time. This is discussed in detail separately (See
         <a class="medical medical_review" href="/z/d/html/5772.html" rel="external">
          "Cardiovascular sequelae of Kawasaki disease: Clinical features and evaluation", section on 'Accelerated atherosclerosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3820200646">
         <span class="h2">
          Childhood cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         As life expectancy for pediatric cancer survivors has improved, it has become increasingly apparent that these patients are at risk for premature ASCVD [
         <a href="#rid69">
          69-71
         </a>
         ]. The increased risk in this population is likely due to a combination of damaged myocardium and direct vascular effect from chemotherapeutic agents, particularly anthracyclines [
         <a href="#rid72">
          72
         </a>
         ]. Radiation therapy, particularly to the mediastinum, is also associated with premature atherosclerosis [
         <a href="#rid73">
          73
         </a>
         ]. In addition, survivors of childhood cancer are more likely to have other ASCVD risk factors including obesity, insulin resistance, and dyslipidemia [
         <a href="#rid74">
          74-79
         </a>
         ]. Issues related to cancer survivorship are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/17017.html" rel="external">
          "Cancer survivorship: Cardiovascular and respiratory issues"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/17015.html" rel="external">
          "Overview of cancer survivorship in adolescents and young adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2493817958">
         <span class="h2">
          Transplant vasculopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         In children who undergo cardiac transplantation, transplant vasculopathy is a significant long-term complication and cause of death [
         <a href="#rid80">
          80
         </a>
         ]. A multicenter autopsy study demonstrated severe coronary stenosis in 28 of 36 children deceased after cardiac transplant [
         <a href="#rid80">
          80
         </a>
         ]. Approximately three-quarters of children with cardiac transplantation have evidence of coronary artery abnormalities detected by angiography and intracoronary ultrasonography [
         <a href="#rid81">
          81,82
         </a>
         ].
        </p>
        <p>
         Cardiac transplant vasculopathy leads to the development of vessel narrowing secondary to thickening of the intimal and medial layers of the coronary. It appears to be multifactorial in origin, with both immunologic and nonimmunologic factors being implicated. Among the factors associated with vasculopathy are cellular and vascular rejection, anti-human leukocyte antigen antibody production, and cytomegalovirus infection. Patients with cardiac transplants are likely to have other ASCVD risk factors, such as dyslipidemia, hypertension, elevated body mass index (BMI), DM, and deconditioning. Similar to children who undergo renal transplantation, these additional risk factors may be associated with medications used to prevent rejection. (See
         <a class="medical medical_review" href="/z/d/html/3517.html" rel="external">
          "Heart transplantation in adults: Cardiac allograft vasculopathy pathogenesis and risk factors"
         </a>
         .)
        </p>
        <p>
         The management of patients with cardiac transplantation to prevent and treat cardiac transplant vasculopathy, as well as to screen and treat dyslipidemia, is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3524.html" rel="external">
          "Heart Transplantation: Prevention and treatment of cardiac allograft vasculopathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3521.html" rel="external">
          "Heart transplantation: Hyperlipidemia after transplantation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3501529534">
         <span class="h2">
          Congenital heart disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital heart disease (CHD) occurs in approximately 1 percent of live births. Because of improvements in surgical, transcatheter, and perioperative management, many more children with CHD are surviving to adulthood in the contemporary era compared with previous eras. As a result, there is increasing evidence that some CHD defects are associated with an increased risk for premature ASCVD.
        </p>
        <p>
         Risk of ASCVD is likely to be greatest in those with coronary artery abnormalities or left-sided obstructive lesions.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Coronary artery abnormalities
         </strong>
         – In patients with coronary artery anomalies, premature atherosclerosis of the coronary artery has been demonstrated in autopsies [
         <a href="#rid83">
          83
         </a>
         ] and detected by coronary artery angiography [
         <a href="#rid84">
          84
         </a>
         ]. In addition, surgical manipulation of the coronary arteries, especially associated with the arterial switch operation for transposition of the great arteries, is associated with increased risk for coronary artery stenosis, premature atherosclerosis, and coronary artery dysfunction [
         <a href="#rid85">
          85-87
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15851.html" rel="external">
          "D-transposition of the great arteries (D-TGA): Management and outcome", section on 'Early atherosclerotic coronary artery disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Left-sided obstructive lesions
         </strong>
         – Cardiac lesions that obstruct the left ventricle or aorta, such as aortic stenosis and coarctation, are associated with an increased risk of ASCVD in adulthood. In children with coarctation of the aorta, the aorta is less compliant and reactive and the CIMT and femoral IMT is increased [
         <a href="#rid88">
          88
         </a>
         ]. Hypertension is common in patients with coarctation, even years after apparently successful repair. (See
         <a class="medical medical_review" href="/z/d/html/5775.html" rel="external">
          "Valvar aortic stenosis in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5760.html" rel="external">
          "Clinical manifestations and diagnosis of coarctation of the aorta"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Comorbid obesity
         </strong>
         – Children with CHD are not immune to the obesity epidemic. Observational data suggest the prevalence of overweight and obesity in children with CHD is similar to that of the general population [
         <a href="#rid89">
          89,90
         </a>
         ]. However, the physiologic consequences of obesity may be greater in the CHD population.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3044462140">
         <span class="h2">
          Chronic inflammatory diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is well established that the prevalence of ASCVD is increased in adults with chronic inflammatory illnesses, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. Increasing evidence suggests that children and adolescents affected by these disorders often have increased ASCVD risk factors [
         <a href="#rid58">
          58
         </a>
         ], with nearly three-quarters reported to have accelerated atherosclerosis associated with dyslipidemia, and a higher risk of premature ASCVD [
         <a href="#rid91">
          91
         </a>
         ]. Children and adolescents with SLE have increased CIMT compared with healthy controls [
         <a href="#rid92">
          92
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6420.html" rel="external">
          "Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis", section on 'Cardiac'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4683.html" rel="external">
          "Coronary artery disease in systemic lupus erythematosus"
         </a>
         .)
        </p>
        <p>
         It is unclear if patients with coronavirus disease 2019 (COVID-19)-associated multisystem inflammatory syndrome in children (MIS-C) are at increased risk for premature ASCVD since long-term follow-up data are not available. Cardiac involvement is common in MIS-C, but the frequency of coronary involvement may be less than in Kawasaki disease. Follow-up in patients with MIS-C is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/129614.html" rel="external">
          "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome", section on 'Follow-up'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2532604314">
         <span class="h2">
          HIV infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Considerable progress has been made in the treatment and prevention of pediatric HIV infection, and life expectancy for HIV-infected children has improved considerably in the era of potent antiretroviral therapy. However, in children infected with HIV early in life, prolonged exposure to HIV and antiretroviral therapy is associated with a number of long-term complications, including dyslipidemia, DM, lipodystrophy, and hypertension [
         <a href="#rid93">
          93
         </a>
         ]. For instance, patients with perinatally acquired HIV infection have been found to have indirect evidence of subclinical coronary vascular disease (ie, increased coronary artery wall thickness) [
         <a href="#rid94">
          94,95
         </a>
         ]. ASCVD risk in youth with perinatal HIV infection is likely multifactorial. In addition to traditional ASCVD risk factors, chronic inflammation, abnormal immune function, side effects of antiretroviral therapy, and direct HIV viral effects may contribute. Long-term morbidities in HIV-infected children are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5963.html" rel="external">
          "Pediatric HIV infection: Classification, clinical manifestations, and outcome", section on 'Long-term morbidities'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1911818373">
         <span class="h2">
          Depressive and bipolar disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Growing evidence suggests that major depressive disorder and bipolar disorder in adolescence may be associated with premature ASCVD. The mechanism appears to be multifactorial and multiple systemic processes have been implicated, including inflammation, oxidative stress, and autonomic dysfunction [
         <a href="#rid96">
          96
         </a>
         ]. The association between depressive and bipolar disorders, particularly major depression, and ASCVD in adults is well established. (See
         <a class="medical medical_review" href="/z/d/html/4854.html" rel="external">
          "Psychosocial factors in acute coronary syndrome", section on 'Depression'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4862.html" rel="external">
          "Psychosocial factors in coronary and cerebral vascular disease"
         </a>
         .)
        </p>
        <p>
         Depressive and bipolar disorders that begin in childhood or adolescence can persist into adulthood. In addition, many traditional ASCVD risk factors (eg, DM, obesity, sedentary lifestyle, smoking) are more prevalent among adolescents with major depressive disorder and bipolar disorder compared with the general pediatric population [
         <a href="#rid96">
          96
         </a>
         ]. In observational studies of adolescents and young adults, the relationship between major depressive disorder and bipolar disorder and indirect measures of atherosclerosis (ie, CIMT, ultrasound-determined brachial artery flow-mediated dilation, or digital pulse-wave amplitude) is inconsistent [
         <a href="#rid96">
          96
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1224.html" rel="external">
          "Pediatric unipolar depression: Epidemiology, clinical features, assessment, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15924.html" rel="external">
          "Pediatric bipolar disorder: Clinical manifestations and course of illness"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2960855">
         <span class="h1">
          PRENATAL FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is emerging evidence that prenatal factors impact offspring cardiovascular health in adulthood. These include fetal growth restriction; gestational and pregestational diabetes mellitus; and maternal factors such as hypertension, hyperlipidemia, prenatal smoking, and excessive weight gain during pregnancy [
         <a href="#rid97">
          97-99
         </a>
         ]. Studies have demonstrated that fetal growth restriction is associated with an increased risk of insulin resistance, ASCVD risk factors (eg, dyslipidemia, hypertension, and elevated C-reactive protein), and vascular dysfunction [
         <a href="#rid100">
          100,101
         </a>
         ]. However, additional research is needed to determine the relative contribution of fetal factors compared with the known contributions of the postnatal risk factors, as discussed above.
        </p>
        <p class="headingAnchor" id="H2682157971">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110734.html" rel="external">
          "Society guideline links: Lipid disorders and atherosclerosis in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atherosclerotic changes in childhood
         </strong>
         – Although atherosclerotic cardiovascular disease (ASCVD) generally manifests clinically in adulthood, there is that atherosclerosis can begin in childhood. A childhood origin of ASCVD is supported by direct evidence from autopsy studies and indirect data showing subclinical vascular changes. (See
         <a class="local">
          'Atherosclerotic changes in childhood'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Traditional risk factors
         </strong>
         – Traditional ASCVD risk factors include  (
         <a class="graphic graphic_table graphicRef109927" href="/z/d/graphic/109927.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Traditional ASCVD risk factors'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dyslipidemia (see
         <a class="local">
          'Dyslipidemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/16972.html" rel="external">
          "Dyslipidemia in children and adolescents: Definition, screening, and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Overweight/obesity (see
         <a class="local">
          'Obesity'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5874.html" rel="external">
          "Definition, epidemiology, and etiology of obesity in children and adolescents"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diabetes mellitus (DM; type 1 or 2) (see
         <a class="local">
          'Diabetes mellitus'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypertension (see
         <a class="local">
          'Hypertension'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6111.html" rel="external">
          "Epidemiology, risk factors, and etiology of hypertension in children and adolescents"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Family history of premature ASCVD (see
         <a class="local">
          'Family history'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Smoking/nicotine exposure (see
         <a class="local">
          'Nicotine exposure'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6375.html" rel="external">
          "Secondhand smoke exposure: Effects in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14583.html" rel="external">
          "Prevention of smoking and vaping initiation in children and adolescents"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other conditions
         </strong>
         – Other conditions associated with increased risk of premature CVD include  (
         <a class="graphic graphic_table graphicRef109927" href="/z/d/graphic/109927.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Other conditions'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Familial hypercholesterolemia (FH) (see
         <a class="local">
          'Familial hypercholesterolemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/121831.html" rel="external">
          "Familial hypercholesterolemia in children"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic kidney disease (CKD) (see
         <a class="local">
          'Chronic kidney disease'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/128353.html" rel="external">
          "Chronic kidney disease in children: Complications", section on 'Risk for cardiovascular disease'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Kawasaki disease (see
         <a class="local">
          'Kawasaki disease'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5772.html" rel="external">
          "Cardiovascular sequelae of Kawasaki disease: Clinical features and evaluation", section on 'Accelerated atherosclerosis'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Childhood cancer (See
         <a class="local">
          'Childhood cancer'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/17017.html" rel="external">
          "Cancer survivorship: Cardiovascular and respiratory issues"
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Transplant vasculopathy (see
         <a class="local">
          'Transplant vasculopathy'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Certain congenital heart disease (CHD) defects and cardiomyopathies (see
         <a class="local">
          'Congenital heart disease'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic inflammatory disease (eg, systemic lupus erythematosus [SLE]) (see
         <a class="local">
          'Chronic inflammatory diseases'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4683.html" rel="external">
          "Coronary artery disease in systemic lupus erythematosus"
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HIV (see
         <a class="local">
          'HIV infection'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5963.html" rel="external">
          "Pediatric HIV infection: Classification, clinical manifestations, and outcome", section on 'Long-term morbidities'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adolescent mood disorders (see
         <a class="local">
          'Depressive and bipolar disorders'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4862.html" rel="external">
          "Psychosocial factors in coronary and cerebral vascular disease"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H191509693">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Jane Newburger, MD, MPH, and Michael Mendelson, MD, ScM, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGill HC Jr, McMahan CA, Zieske AW, et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000; 20:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGill HC Jr, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol 1998; 82:30T.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McMahan CA, Gidding SS, Malcom GT, et al. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics 2006; 118:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McMahan CA, Gidding SS, Malcom GT, et al. Comparison of coronary heart disease risk factors in autopsied young adults from the PDAY Study with living young adults from the CARDIA study. Cardiovasc Pathol 2007; 16:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webber BJ, Seguin PG, Burnett DG, et al. Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011. JAMA 2012; 308:2577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groner JA, Joshi M, Bauer JA. Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics 2006; 118:1683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aggoun Y, Szezepanski I, Bonnet D. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events in children. Pediatr Res 2005; 58:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation 2001; 104:2815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 2003; 290:2271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003; 290:2277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dawson JD, Sonka M, Blecha MB, et al. Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the Muscatine Offspring Study. J Am Coll Cardiol 2009; 53:2273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juonala M, Magnussen CG, Venn A, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation 2010; 122:2514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryder JR, Dengel DR, Jacobs DR Jr, et al. Relations among Adiposity and Insulin Resistance with Flow-Mediated Dilation, Carotid Intima-Media Thickness, and Arterial Stiffness in Children. J Pediatr 2016; 168:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaeta G, De Michele M, Cuomo S, et al. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med 2000; 343:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kusters DM, Wiegman A, Kastelein JJ, Hutten BA. Carotid intima-media thickness in children with familial hypercholesterolemia. Circ Res 2014; 114:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006; 74:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urbina EM, Kimball TR, McCoy CE, et al. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation 2009; 119:2913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juonala M, Wu F, Sinaiko A, et al. Non-HDL Cholesterol Levels in Childhood and Carotid Intima-Media Thickness in Adulthood. Pediatrics 2020; 145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alpert BS, Collins RT. Assessment of vascular function: pulse wave velocity. J Pediatr 2007; 150:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Im JA, Lee JW, Shim JY, et al. Association between brachial-ankle pulse wave velocity and cardiovascular risk factors in healthy adolescents. J Pediatr 2007; 150:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li S, Chen W, Srinivasan SR, Berenson GS. Childhood blood pressure as a predictor of arterial stiffness in young adults: the bogalusa heart study. Hypertension 2004; 43:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urbina EM, Dolan LM, McCoy CE, et al. Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr 2011; 158:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urbina EM, Kimball TR, Khoury PR, et al. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens 2010; 28:1692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juonala M, Viikari JS, Kähönen M, et al. Life-time risk factors and progression of carotid atherosclerosis in young adults: the Cardiovascular Risk in Young Finns study. Eur Heart J 2010; 31:1745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koskinen J, Kähönen M, Viikari JS, et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study. Circulation 2009; 120:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juonala M, Järvisalo MJ, Mäki-Torkko N, et al. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 2005; 112:1486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juonala M, Viikari JS, Rönnemaa T, et al. Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study. Hypertension 2006; 48:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartiala O, Magnussen CG, Kajander S, et al. Adolescence risk factors are predictive of coronary artery calcification at middle age: the cardiovascular risk in young Finns study. J Am Coll Cardiol 2012; 60:1364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartiala O, Kajander S, Knuuti J, et al. Life-course risk factor levels and coronary artery calcification. The Cardiovascular Risk in Young Finns Study. Int J Cardiol 2016; 225:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu F, Ahola-Olli A, Pahkala K, et al. Risk Factor Profile in Youth, Genetic Risk, and Adulthood Cognitive Function: The Cardiovascular Risk in Young Finns Study. Neuroepidemiology 2022; 56:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rovio SP, Pahkala K, Nevalainen J, et al. Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study. J Am Coll Cardiol 2017; 69:2279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkins JT, Li RC, Sniderman A, et al. Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study. J Am Coll Cardiol 2016; 67:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loria CM, Liu K, Lewis CE, et al. Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J Am Coll Cardiol 2007; 49:2013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs DR Jr, Woo JG, Sinaiko AR, et al. Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events. N Engl J Med 2022; 386:1877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Magnussen CG, Venn A, Thomson R, et al. The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J Am Coll Cardiol 2009; 53:860.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koskinen J, Juonala M, Dwyer T, et al. Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: International Childhood Cardiovascular Cohort Consortium. Circulation 2018; 137:1246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5:S213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Ferranti SD, Steinberger J, Ameduri R, et al. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. Circulation 2019; 139:e603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson SL, Zhang Z, Wiltz JL, et al. Hypertension Among Youths - United States, 2001-2016. MMWR Morb Mortal Wkly Rep 2018; 67:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kit BK, Kuklina E, Carroll MD, et al. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr 2015; 169:272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics 2012; 129:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perak AM, Ning H, Kit BK, et al. Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016. JAMA 2019; 321:1895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Juhola J, Magnussen CG, Viikari JS, et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. J Pediatr 2011; 159:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saydah S, Bullard KM, Imperatore G, et al. Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality. Pediatrics 2013; 131:e679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedemann C, Heneghan C, Mahtani K, et al. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ 2012; 345:e4759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357:2329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batty GD, Calvin CM, Brett CE, et al. Childhood Body Weight in Relation to Cause-Specific Mortality: 67 Year Follow-up of Participants in the 1947 Scottish Mental Survey. Medicine (Baltimore) 2016; 95:e2263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic Risks and Severity of Obesity in Children and Young Adults. N Engl J Med 2015; 373:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haller MJ, Stein J, Shuster J, et al. Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatr Diabetes 2007; 8:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007; 120:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haney EM, Huffman LH, Bougatsos C, et al. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics 2007; 120:e189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ritchie SK, Murphy EC, Ice C, et al. Universal versus targeted blood cholesterol screening among youth: The CARDIAC project. Pediatrics 2010; 126:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004; 291:2204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghuveer G, White DA, Hayman LL, et al. Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association. Circulation 2016; 134:e336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140:e596.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114:2710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nayir A, Bilge I, Kiliçaslan I, et al. Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 2001; 16:2041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Litwin M, Grenda R, Prokurat S, et al. Patient survival and causes of death on hemodialysis and peritoneal dialysis--single-center study. Pediatr Nephrol 2001; 16:996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitsnefes MM, Kimball TR, Witt SA, et al. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 2003; 107:864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hussein G, Bughdady Y, Kandil ME, et al. Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr Nephrol 2008; 23:2025.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Litwin M, Wühl E, Jourdan C, et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 2008; 23:2552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Covic A, Mardare N, Gusbeth-Tatomir P, et al. Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant 2006; 21:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakiler AR, Yavascan O, Harputluoglu N, et al. Evaluation of aortic stiffness in children with chronic renal failure. Pediatr Nephrol 2007; 22:1911.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skrzypczyk P, Kuźma-Mroczkowska E, Kułagowska J, et al. Carotid intima-media thickness in children with idiopathic nephrotic syndrome: A single center cross-sectional study . Clin Nephrol 2019; 91:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bharati J, Tiewsoh K, Dawman L, et al. Long-term complications in patients with childhood-onset nephrotic syndrome. Pediatr Nephrol 2023; 38:1107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahul I, Krishnamurthy S, Satheesh S, et al. Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study. Clin Exp Nephrol 2015; 19:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339:b4606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haddy N, Diallo S, El-Fayech C, et al. Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study. Circulation 2016; 133:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gudmundsdottir T, Winther JF, de Fine Licht S, et al. Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors. Int J Cancer 2015; 137:1176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armenian SH, Armstrong GT, Aune G, et al. Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention. J Clin Oncol 2018; 36:2135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shankar SM, Marina N, Hudson MM, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 2008; 121:e387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neville KA, Cohn RJ, Steinbeck KS, et al. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab 2006; 91:4401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green DM, Hyland A, Chung CS, et al. Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol 1999; 17:3207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003; 21:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birkebaek NH, Fisker S, Clausen N, et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 1998; 30:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lipshultz SE, Lipsitz SR, Hinkle AS, et al. Cardiovascular status, subsequent risk, and associated factors in long-term survivors of childhood cancer in a population-based study. Circulation 2005; 112 (Suppl 2):476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinberger J, Sinaiko AR, Kelly AS, et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. J Pediatr 2012; 160:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation 1994; 90:II56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dent CL, Canter CE, Hirsch R, Balzer DT. Transplant coronary artery disease in pediatric heart transplant recipients. J Heart Lung Transplant 2000; 19:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuhn MA, Jutzy KR, Deming DD, et al. The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. J Am Coll Cardiol 2000; 36:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts WC. Major anomalies of coronary arterial origin seen in adulthood. Am Heart J 1986; 111:941.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Click RL, Holmes DR Jr, Vlietstra RE, et al. Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study. J Am Coll Cardiol 1989; 13:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ou P, Mousseaux E, Azarine A, et al. Detection of coronary complications after the arterial switch operation for transposition of the great arteries: first experience with multislice computed tomography in children. J Thorac Cardiovasc Surg 2006; 131:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pedra SR, Pedra CA, Abizaid AA, et al. Intracoronary ultrasound assessment late after the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol 2005; 45:2061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagliardi MG, Adorisio R, Crea F, et al. Abnormal vasomotor function of the epicardial coronary arteries in children five to eight years after arterial switch operation: an angiographic and intracoronary Doppler flow wire study. J Am Coll Cardiol 2005; 46:1565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vriend JW, de Groot E, de Waal TT, et al. Increased carotid and femoral intima-media thickness in patients after repair of aortic coarctation: influence of early repair. Am Heart J 2006; 151:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinto NM, Marino BS, Wernovsky G, et al. Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics 2007; 120:e1157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasquali SK, Marino BS, Pudusseri A, et al. Risk factors and comorbidities associated with obesity in children and adolescents after the arterial switch operation and Ross procedure. Am Heart J 2009; 158:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ilowite NT, Copperman N, Leicht T, et al. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol 1995; 22:1347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schanberg LE, Sandborg C, Barnhart HX, et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum 2009; 60:1496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel K, Wang J, Jacobson DL, et al. Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus. Circulation 2014; 129:1204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abd-Elmoniem KZ, Unsal AB, Eshera S, et al. Increased coronary vessel wall thickness in HIV-infected young adults. Clin Infect Dis 2014; 59:1779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Idris NS, Grobbee DE, Burgner D, et al. Effects of paediatric HIV infection on childhood vasculature. Eur Heart J 2016; 37:3610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein BI, Carnethon MR, Matthews KA, et al. Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2015; 132:965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mendelson MM, Lyass A, O'Donnell CJ, et al. Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study. JAMA Cardiol 2016; 1:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaillard R. Maternal obesity during pregnancy and cardiovascular development and disease in the offspring. Eur J Epidemiol 2015; 30:1141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramakrishnan A, Lee LJ, Mitchell LE, Agopian AJ. Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis. Pediatr Cardiol 2015; 36:1442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skilton MR, Viikari JS, Juonala M, et al. Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2011; 31:2975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson JA, Regnault TR. In utero origins of adult insulin resistance and vascular dysfunction. Semin Reprod Med 2011; 29:211.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5781 Version 47.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9614255" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10938023" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9860371" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015535" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17502244" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Comparison of coronary heart disease risk factors in autopsied young adults from the PDAY Study with living young adults from the CARDIA study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23268516" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015562" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16055929" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Noninvasive assessment of arterial stiffness and risk of atherosclerotic events in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11733400" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14600185" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14600186" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19520251" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the Muscatine Offspring Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21126976" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26427963" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Relations among Adiposity and Insulin Resistance with Flow-Mediated Dilation, Carotid Intima-Media Thickness, and Arterial Stiffness in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10995863" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Arterial abnormalities in the offspring of patients with premature myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24192652" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Carotid intima-media thickness in children with familial hypercholesterolemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16621108" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19470890" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32209701" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Non-HDL Cholesterol Levels in Childhood and Carotid Intima-Media Thickness in Adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17307531" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Assessment of vascular function: pulse wave velocity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17307539" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Association between brachial-ankle pulse wave velocity and cardiovascular risk factors in healthy adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14744922" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Childhood blood pressure as a predictor of arterial stiffness in young adults: the bogalusa heart study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21300369" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20647860" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20501481" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Life-time risk factors and progression of carotid atherosclerosis in young adults: the Cardiovascular Risk in Young Finns study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19581494" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16129802" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16880344" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22981553" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Adolescence risk factors are predictive of coronary artery calcification at middle age: the cardiovascular risk in young Finns study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27697667" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Life-course risk factor levels and coronary artery calcification. The Cardiovascular Risk in Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35552281" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Risk Factor Profile in Youth, Genetic Risk, and Adulthood Cognitive Function: The Cardiovascular Risk in Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28473132" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26791067" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17512357" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35373933" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19264243" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29170152" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: International Childhood Cardiovascular Cohort Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22084329" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30798614" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30001558" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Hypertension Among Youths - United States, 2001-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25599372" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22614778" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31112258" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21514597" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23420920" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23015032" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18057335" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Childhood body-mass index and the risk of coronary heart disease in adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26871765" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Childhood Body Weight in Relation to Cause-Specific Mortality: 67 Year Follow-up of Participants in the 1947 Scottish Mental Survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26422721" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Cardiometabolic Risks and Severity of Obesity in Children and Young Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17659060" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17671060" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19139390" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17606543" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20624798" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Universal versus targeted blood cholesterol screening among youth: The CARDIAC project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15138242" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27619923" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30879355" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17130340" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11572894" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Arterial changes in paediatric haemodialysis patients undergoing renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11793088" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Patient survival and causes of death on hemodialysis and peritoneal dialysis--single-center study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12591757" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Left ventricular mass and systolic performance in pediatric patients with chronic renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18543003" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18344239" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16221688" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Increased arterial stiffness in children on haemodialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17710441" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Evaluation of aortic stiffness in children with chronic renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31079597" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Carotid intima-media thickness in children with idiopathic nephrotic syndrome: A single center cross-sectional study .
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35943575" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Long-term complications in patients with childhood-onset nephrotic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24639030" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19996459" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26487757" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25648592" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29874141" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18187811" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16954158" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10506620" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12663727" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9589084" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Cardiovascular status, subsequent risk, and associated factors in long-term survivors of childhood cancer in a population-based study
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21920542" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Cardiovascular risk and insulin resistance in childhood cancer survivors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7955283" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Posttransplant coronary artery disease in children. A multicenter national survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10713248" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Transplant coronary artery disease in pediatric heart transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10898442" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3518378" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Major anomalies of coronary arterial origin seen in adulthood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2918156" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16515917" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Detection of coronary complications after the arterial switch operation for transposition of the great arteries: first experience with multislice computed tomography in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15963410" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Intracoronary ultrasound assessment late after the arterial switch operation for transposition of the great arteries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16226186" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Abnormal vasomotor function of the epicardial coronary arteries in children five to eight years after arterial switch operation: an angiographic and intracoronary Doppler flow wire study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16368325" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Increased carotid and femoral intima-media thickness in patients after repair of aortic coarctation: influence of early repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17974711" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Obesity is a common comorbidity in children with congenital and acquired heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19699873" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Risk factors and comorbidities associated with obesity in children and adolescents after the arterial switch operation and Ross procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7562770" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19404953" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24366631" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25159580" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Increased coronary vessel wall thickness in HIV-infected young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26746627" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Effects of paediatric HIV infection on childhood vasculature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26260736" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27437650" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26377700" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Maternal obesity during pregnancy and cardiovascular development and disease in the offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25951814" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21940950" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21710397" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : In utero origins of adult insulin resistance and vascular dysfunction.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
